Amgen (AMGN) insider trading

By person

22 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Robert A Bradway

Chairman, CEO and President

—

595,160

$247.84M

−2.8%

Esteban Santos

EVP, Operations

—

82,847

$34.50M

+14.9%

Murdo Gordon

EVP, Global Commercial Ops

—

51,222

$21.33M

−4.4%

Peter H. Griffith

EVP & CFO

—

50,150

$20.88M

+36.3%

David M Reese

EVP & Chief Technology Officer

—

42,256

$17.60M

−32.6%

Jonathan P Graham

EVP & Gen. Counsel & Sec.

—

39,712

$16.54M

+10.6%

James E. Bradner

EVP, Research and Development

—

30,016

$12.50M

+10.8%

Robert Eckert

Director

—

26,251

$10.93M

+5.9%

Tyler Jacks

Director

—

18,284

$7.61M

+8.8%

Ellen Jamison Kullman

Director

—

14,536

$6.05M

+11.3%

Greg C. Garland

Director

—

13,848

$5.77M

+11.9%

Charles M Holley

Director

—

12,990

$5.41M

+21.2%

Derek Miller

SVP, Human Resources

—

12,462

$5.19M

+35.3%

Brian Druker

Director

—

8,391

$3.49M

+21.3%

Wanda M Austin

Director

—

8,018

$3.34M

+22.5%

Omar Ishrak

Director

—

7,486

$3.12M

+39.9%

Nancy A. Grygiel

SVP & CCO

—

7,340

$3.06M

−17.6%

Rachna Khosla

SVP, Business Development

—

6,404

$2.67M

−24.8%

Michael Drake V

Director

—

5,876

$2.45M

+55.1%

Amy E Miles

Director

—

5,640

$2.35M

+35.4%

Matthew C. Busch

VP, Finance & CAO

—

5,080

$2.12M

+4.7%

Mary E. Klotman

Director

—

2,211

$920.72K

+200.0%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Amgen

What the insiders did No buying or selling

By person